Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.

Ricci A, Coppo E, Barbieri R, Debbia EA, Marchese A.

J Chemother. 2017 Apr;29(2):67-73. doi: 10.1080/1120009X.2016.1195069. Epub 2016 Jun 10.

PMID:
27285830
2.

Antimicrobial effect of MTAD, Tetraclean, Cloreximid, and sodium hypochlorite on three common endodontic pathogens.

Giardino L, Savoldi E, Ambu E, Rimondini R, Palezona A, Debbia EA.

Indian J Dent Res. 2009 Jul-Sep;20(3):391. doi: 10.4103/0970-9290.57353.

3.

Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC).

Cassanelli C, Marchese A, Cagnacci S, Debbia EA.

Open Microbiol J. 2008;2:32-7. doi: 10.2174/1874285800802010032. Epub 2008 Apr 15.

4.

Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.

Debbia EA, Maioli E, Roveta S, Marchese A.

J Chemother. 2008 Apr;20(2):186-94.

PMID:
18467244
6.

Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the tigecycline evaluation and surveillance trial.

Rodloff AC, Leclercq R, Debbia EA, Cantón R, Oppenheim BA, Dowzicky MJ.

Clin Microbiol Infect. 2008 Apr;14(4):307-14. doi: 10.1111/j.1469-0691.2007.01943.x. Epub 2008 Feb 2.

7.

In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci.

Roveta S, Marchese A, Debbia EA, Bandettini R.

Int J Antimicrob Agents. 2008 Feb;31(2):185-7. Epub 2007 Dec 21. No abstract available.

PMID:
18082375
8.

Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.

Roveta S, Marchese A, Debbia EA.

Chemotherapy. 2008;54(1):43-9. Epub 2007 Dec 10.

PMID:
18073470
9.

Comparative evaluation of antimicrobial efficacy of sodium hypochlorite, MTAD, and Tetraclean against Enterococcus faecalis biofilm.

Giardino L, Ambu E, Savoldi E, Rimondini R, Cassanelli C, Debbia EA.

J Endod. 2007 Jul;33(7):852-5. Epub 2007 Apr 2.

PMID:
17804328
10.

Periodontal disease and coronary heart disease: an epidemiological and microbiological study.

Latronico M, Segantini A, Cavallini F, Mascolo A, Garbarino F, Bondanza S, Debbia EA, Blasi G.

New Microbiol. 2007 Jul;30(3):221-8.

11.

In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens.

Maioli E, Marchese A, Roveta S, Cagnacci S, Cavallini F, Cassanelli C, Gualco L, Debbia EA.

J Chemother. 2007 Apr;19(2):152-60.

PMID:
17434823
12.

Records matching model for data survey on applied and experimental microbiology.

Reina SA, Reina VM, Debbia EA.

New Microbiol. 2007 Jan;30(1):35-44.

13.

Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.

Gualco L, Debbia EA, Bandettini R, Pescetto L, Cavallero A, Ossi MC, Schito AM, Marchese A.

Int J Antimicrob Agents. 2007 Feb;29(2):179-84. Epub 2006 Dec 18.

PMID:
17175140
14.

Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system.

Roveta S, Marchese A, Debbia EA.

J Chemother. 2006 Feb;18(1):12-9.

PMID:
16572888
15.

Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders.

Debbia EA, Dolcino M, Marchese A, Piazzi A, Berio A.

New Microbiol. 2004 Oct;27(4):361-7.

PMID:
15646050
16.

In vitro activity of ertapenem against selected respiratory pathogens.

Marchese A, Gualco L, Schito AM, Debbia EA, Schito GC.

J Antimicrob Chemother. 2004 Nov;54(5):944-51. Epub 2004 Oct 7.

PMID:
15472001
17.
18.

Pleiotropic effect of sodium arsenite on Escherichia coli.

Gualco L, Roveta S, Marchese A, Debbia EA.

Res Microbiol. 2004 May;155(4):275-82.

PMID:
15142625
19.
20.

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms.

Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM.

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:95-100.

PMID:
14527779
21.

In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance.

Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM.

Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:53-9.

PMID:
14527772
22.
23.

Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.

Dolcino M, Zoratti A, Debbia EA, Schito GC, Marchese A.

Antimicrob Agents Chemother. 2002 Dec;46(12):4022-5.

24.

Microbial epidemiology patterns of surgical infection pathogens.

Debbia EA, Schito GC, Gualco L, Tonoli E, Dolcino M, Marchese A.

J Chemother. 2001 Nov;13 Spec No 1(1):84-8. Review.

PMID:
11936386
25.

Epidemiology of major respiratory pathogens.

Debbia EA, Schito GC, Zoratti A, Gualco L, Tonoli E, Marchese A.

J Chemother. 2001 Nov;13 Spec No 1(1):205-10. Review.

PMID:
11936367
26.

In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy.

Marchese A, Debbia EA, Schito GC.

Clin Microbiol Infect. 1999 Aug;5(8):488-495.

27.

Antimicrobial activity of faropenem, a new oral penem, against lower respiratory tract pathogens.

Marchese A, Debbia EA, Bryskier A, Schito GC.

Clin Microbiol Infect. 1999 May;5(5):282-287. No abstract available.

28.

Antibiotic persistence: the role of spontaneous DNA repair response.

Debbia EA, Roveta S, Schito AM, Gualco L, Marchese A.

Microb Drug Resist. 2001 Winter;7(4):335-42.

PMID:
11822773
29.

[Bacterial synergy in postsurgical infective complications in gynecology].

Debbia EA, Marchese A, Schito GC.

Minerva Ginecol. 2000 Dec;52(12 Suppl 1):135-8. Italian. No abstract available.

PMID:
11526682
30.

[Emergence of drug-resistant gram-positive pathogenic bacteria].

Marchese A, Schito GC, Debbia EA.

J Chemother. 2000 Jul;12 Suppl 2:12-4. Italian.

PMID:
11428095
31.

Evaluation of spontaneous contamination of ocular medications.

Marchese A, Bozzolasco M, Gualco L, Schito GC, Debbia EA.

Chemotherapy. 2001 Jul-Aug;47(4):304-8.

PMID:
11399868
32.

Evolution of antibiotic resistance in gram-positive pathogens.

Marchese A, Schito GC, Debbia EA.

J Chemother. 2000 Dec;12(6):459-62.

PMID:
11154025
33.

Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project.

Marchese A, Debbia EA, Schito GC.

J Antimicrob Chemother. 2000 Jul;46 Suppl T1:11-5.

PMID:
10997594
34.

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.

Schito GC, Debbia EA, Marchese A.

J Antimicrob Chemother. 2000 Jul;46 Suppl T1:3-9.

PMID:
10997593
35.

Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe.

Debbia EA, Shito GC, Pesce A, Marchese A.

Infection. 1999;27 Suppl 2:S9-12.

PMID:
10885819
37.

[Peptide antibiotics].

Debbia EA.

Recenti Prog Med. 2000 Mar;91(3):106-8. Review. Italian. No abstract available.

PMID:
10763339
38.

Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital.

Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC.

J Clin Microbiol. 2000 Feb;38(2):866-9.

39.

[Antibiotic resistance: an always present problem].

Debbia EA.

Recenti Prog Med. 1999 Oct;90(10):505-9. Review. Italian. No abstract available.

PMID:
10592734
40.
41.

Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy.

Marchese A, Tonoli E, Debbia EA, Schito GC.

J Antimicrob Chemother. 1999 Oct;44(4):461-4.

PMID:
10588306
42.

Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin.

Soro O, Pesce A, Raggi M, Debbia EA, Schito GC.

Clin Microbiol Infect. 1997 Feb;3(1):147-151. No abstract available.

43.

Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.

Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.

Drugs. 1997;54 Suppl 6:11-20.

PMID:
9474477
45.
46.

In vitro activity of metronidazole alone and in combination with clotrimazole against clinical isolates of Trichomonas vaginalis.

Debbia EA, Campora U, Massaro S, Boldrini E, Schito GC.

J Chemother. 1996 Apr;8(2):96-101.

PMID:
8708753
48.

Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics.

Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GC.

J Antimicrob Chemother. 1995 Nov;36(5):833-7.

PMID:
8626265
49.

[In vitro antibacterial activity of meropenem, a new carbapenem: European data].

Debbia EA, Marchese A, Pesce A, Schito GC.

New Microbiol. 1995 Oct;18 Suppl:1S-17S. Italian.

PMID:
8574928
50.

The beta-lactamase problem: new therapeutic options.

Schito GC, Pesce A, Debbia EA, Marchese A.

J Chemother. 1995 May;7 Suppl 1:5-8. Review.

PMID:
8618111

Supplemental Content

Loading ...
Support Center